UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

Send a link to a friend  Share

[October 21, 2021]  (Reuters) - The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on Thursday.

Medicines and Healthcare products Regulatory Agency's (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Shinjini Ganguli)

[© 2021 Thomson Reuters. All rights reserved.]

Copyright 2021 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content

 

Back to top